Joseph Oliveto
President and Chief Executive Officer, Milestone Pharmaceuticals
Replay available
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call
Milestone Pharmaceuticals Inc. (NASDAQ: MIST) Q1 2026 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Michael Wood
Host, LifeSci Advisors
Amit Hasija
Chief Financial Officer and EVP of Corporate Development, Milestone Pharmaceuticals
Brandon Fawkes
Analyst, H.C. Wainwright & Co.
Lorenz Muller
Chief Commercial Officer, Milestone Pharmaceuticals
Tiago Ford
Analyst, Raymond James
Ritu Barao
Analyst, Cowen & Company
Ted Tenthoff
Analyst, Piper Sandler
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Milestone Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:01.448 -- 00:00:06.454 Ladies and gentlemen, good morning and welcome to the Milestone Pharma first quarter 00:00:06.454 -- 00:00:11.780 2026 earnings conference call. At this time, all participants are in listen-only 00:00:11.780 -- 00:00:17.186 mode. A brief question and answer session will follow the formal presentation. 00:00:17.186 -- 00:00:21.571 If anyone requires operator assistance during the conference, please signal the operator 00:00:21.571 -- 00:00:25.595 by pressing star and zero on your telephone keypad. 00:00:25.595 -- 00:00:28.786 As a reminder, this conference is being recorded. 00:00:28.786 -- 00:00:33.533 It is now my pleasure to introduce your host, Michael Wood of LifeSci Advisors. 00:00:33.533 -- 00:00:35.953 Please go ahead. 00:00:36.497 -- 00:00:40.463 Thank you, operator. Good morning, everyone, and welcome to the Milestone Pharmaceuticals 00:00:40.463 -- 00:00:42.526 first quarter 2026 00:00:42.526 -- 00:00:46.431 financial results and business update conference call. 00:00:46.431 -- 00:00:50.697 Earlier this morning, the company issued a press release providing an overview of its 00:00:50.697 -- 00:00:55.544 financial results for the quarter ended March 31, 2026 and 00:00:55.544 -- 00:00:59.804 recent corporate highlights. The release can be accessed on the investors and meters 00:00:59.804 -- 00:01:03.886 section of the company's website, milestonepharma.com. 00:01:04.729 -- 00:01:08.372 Before we begin, I'd like to remind you that some of the information presented on this 00:01:08.372 -- 00:01:13.237 conference call contains forward-looking statements under the securities laws. 00:01:13.237 -- 00:01:17.341 These forward-looking statements involve substantial risks and uncertainties that could 00:01:17.341 -- 00:01:22.186 cau...